Associations of functional, psychosocial, and medical factors with cognitive impairment in older, chemotherapy naïve patients with early breast cancer.
作者信息
Nakamura Zev M, Deal Allison M, Nyrop Kirsten A, Damone Emily M, Muss Hyman B
机构信息
Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
出版信息
Psychooncology. 2020 Aug;29(8):1366-1369. doi: 10.1002/pon.5433. Epub 2020 Jun 8.
Abstract
摘要
相似文献
1
Associations of functional, psychosocial, and medical factors with cognitive impairment in older, chemotherapy naïve patients with early breast cancer.
Psychooncology. 2020 Aug;29(8):1366-1369. doi: 10.1002/pon.5433. Epub 2020 Jun 8.
2
Associations of functional, psychosocial, medical, and socio-demographic factors with cognitive screening in chemotherapy naïve patients with breast cancer.
Psychooncology. 2019 Jan;28(1):167-173. doi: 10.1002/pon.4928. Epub 2018 Nov 8.
3
Electroacupuncture trigeminal nerve stimulation plus body acupuncture for chemotherapy-induced cognitive impairment in breast cancer patients: An assessor-participant blinded, randomized controlled trial.
Brain Behav Immun. 2020 Aug;88:88-96. doi: 10.1016/j.bbi.2020.04.035. Epub 2020 Apr 16.
4
'A new normal with chemobrain': Experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors.
Health Psychol Open. 2019 Mar 5;6(1):2055102919832234. doi: 10.1177/2055102919832234. eCollection 2019 Jan-Jun.
5
Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain.
Neuropharmacology. 2018 May 1;133:451-461. doi: 10.1016/j.neuropharm.2018.02.013.
6
Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats.
Biosci Biotechnol Biochem. 2020 Jun;84(6):1201-1210. doi: 10.1080/09168451.2020.1722057. Epub 2020 Jan 28.
7
Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology.
Expert Rev Hematol. 2020 Apr;13(4):393-404. doi: 10.1080/17474086.2020.1738213. Epub 2020 Mar 10.
8
Renaming "chemobrain".
Cancer Invest. 2007 Sep;25(6):373-7. doi: 10.1080/07357900701506672.
9
Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Exp Neurol. 2020 Feb;324:113118. doi: 10.1016/j.expneurol.2019.113118. Epub 2019 Nov 19.
10
Chemobrain: A Pilot Study Exploring the Severity and Onset of Chemotherapy-Related Cognitive Impairment.
Clin J Oncol Nurs. 2019 Aug 1;23(4):411-416. doi: 10.1188/19.CJON.411-416.
引用本文的文献
1
Comparing Mini-Cog and Blessed Orientation-Memory-Concentration test for evaluating cognition in older patients with advanced cancer.
J Geriatr Oncol. 2024 Jun;15(5):101764. doi: 10.1016/j.jgo.2024.101764. Epub 2024 Apr 16.
2
Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study.
J Clin Oncol. 2023 Jan 10;41(2):295-306. doi: 10.1200/JCO.22.00406. Epub 2022 Sep 30.
3
Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders.
J Geriatr Oncol. 2022 Sep;13(7):987-996. doi: 10.1016/j.jgo.2022.04.010. Epub 2022 Apr 26.
本文引用的文献
1
Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer.
J Geriatr Oncol. 2020 Mar;11(2):284-289. doi: 10.1016/j.jgo.2019.10.004. Epub 2019 Dec 6.
2
Associations of functional, psychosocial, medical, and socio-demographic factors with cognitive screening in chemotherapy naïve patients with breast cancer.
Psychooncology. 2019 Jan;28(1):167-173. doi: 10.1002/pon.4928. Epub 2018 Nov 8.
3
Community Oncologists' Decision-Making for Treatment of Older Patients With Cancer.
J Natl Compr Canc Netw. 2018 Mar;16(3):301-309. doi: 10.6004/jnccn.2017.7047.
4
Cognitive Effects of Cancer and Cancer Treatments.
Annu Rev Clin Psychol. 2018 May 7;14:425-451. doi: 10.1146/annurev-clinpsy-050817-084903. Epub 2018 Jan 18.
5
A review of cognitive screening tools in cancer.
Curr Opin Support Palliat Care. 2017 Mar;11(1):24-31. doi: 10.1097/SPC.0000000000000257.
6
Feasibility of geriatric assessment in community oncology clinics.
J Geriatr Oncol. 2014 Jul;5(3):245-51. doi: 10.1016/j.jgo.2014.03.001. Epub 2014 Apr 3.
7
Four sensitive screening tools to detect cognitive dysfunction in geriatric emergency department patients: brief Alzheimer's Screen, Short Blessed Test, Ottawa 3DY, and the caregiver-completed AD8.
Acad Emerg Med. 2011 Apr;18(4):374-84. doi: 10.1111/j.1553-2712.2011.01040.x.
8
Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401.
J Clin Oncol. 2011 Apr 1;29(10):1290-6. doi: 10.1200/JCO.2010.30.6985. Epub 2011 Feb 28.
9
'Chemobrain' in breast carcinoma?: a prologue.
Cancer. 2004 Aug 1;101(3):466-75. doi: 10.1002/cncr.20393.
10
Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.
Am J Psychiatry. 1983 Jun;140(6):734-9. doi: 10.1176/ajp.140.6.734.
Zotero 插件